Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats
- 1 November 2018
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 64, 162-169
Abstract
No abstract availableKeywords
Funding Information
- State Natural Sciences Fund of China (81703594, 81603177)
- Natural Science Fund of Hubei Province, China (2017CFB564)
- Natural Science Fund of Health and Family Planning Commission of Wuhan Municipality, China (WZ17Q05)
This publication has 40 references indexed in Scilit:
- Personalized Medicine for the Management of Benign Prostatic HyperplasiaJournal of Urology, 2014
- Preventive Effects of Lignan Extract from Flax Hulls on Experimentally Induced Benign Prostate HyperplasiaJournal of Medicinal Food, 2014
- Molecular mechanisms of epithelial–mesenchymal transitionNature Reviews Molecular Cell Biology, 2014
- Key Role of MicroRNA in the Regulation of Granulocyte Macrophage Colony-stimulating Factor Expression in Murine Alveolar Epithelial Cells during Oxidative StressJournal of Biological Chemistry, 2014
- Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in ratsToxicology Letters, 2013
- Androgens and estrogens in benign prostatic hyperplasia: Past, present and futureDifferentiation, 2011
- Epigenetic Control of Estrogen Receptor Expression and Tumor Suppressor Genes Is Modulated by Bioactive Food CompoundsAnnals of Nutrition and Metabolism, 2010
- HIF-1 in the inflammatory microenvironmentExperimental Cell Research, 2009
- Green tea polyphenols inhibit testosterone production in rat Leydig cellsAsian Journal of Andrology, 2009
- Androgens and Benign Prostatic HyperplasiaEuropean Urology Supplements, 2006